Related Experiment Video
Updated: May 25, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of
Yi-Feng Huang1, Jing-Jer Lin, Chao-Hsiung Lin
1Department of Life Sciences, Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan.
Abstract:
Runx2 plays a crucial role in osteoblastic differentiation, which can be upregulated by bone morphogenetic proteins 2 (BMP2). Mitogen-activated protein kinase (MAPK) cascades, such as extracellular signal-regulated kinase (ERK) and p38, have been reported to be activated by BMP2 to increase Runx2 activity. The role of cjun-N-terminal kinase (JNK), the other kinase of MAPK, in osteoblastic differentiation has not been well elucidated. In this study, we first showed that JNK1 is activated by BMP2 in multipotent C2C12 and preosteoblastic MC3T3-E1 cell lines. We then showed that early and late osteoblastic differentiation, represented by ALP expression and mineralization, respectively, are significantly enhanced by JNK1 loss-of-function, such as treatment of JNK inhibitor, knockdown of JNK1 and ectopic expression of a dominant negative JNK1 (DN-JNK1). Consistently, BMP2-induced osteoblastic differentiation is reduced by JNK1 gain-of-function, such as enforced expression of a constitutively active JNK1 (CA-JNK1). Most importantly, we showed that Runx2 is required for JNK1-mediated inhibition of osteoblastic differentiation, and identified Ser104 of Runx2 is the site phosphorylated by JNK1 upon BMP2 stimulation. Finally, we found that overexpression of the mutant Runx2 (Ser104Ala) stimulates osteoblastic differentiation of C2C12 and MC3T3-E1 cells to the extent similar to that achieved by overexpression of wild-type (WT) Runx2 plus JNK inhibitor treatment. Taken together, these data indicate that JNK1 negatively regulates BMP2-induced osteoblastic differentiation through phosphorylation of Runx2 at Ser104. In addition, unraveling these mechanisms may help to develop new strategies in enhancing osteoblastic differentiation and bone formation.
Insights
JNK1 activation by bone morphogenetic protein 2 (BMP2) inhibits osteoblastic differentiation by phosphorylating Runx2 at Ser104. Inhibiting JNK1 enhances osteoblast differentiation, offering new strategies for bone formation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Runx2 is essential for osteoblastic differentiation, often upregulated by BMP2.
- MAPK pathways, including ERK and p38, are activated by BMP2 to enhance Runx2 activity.
- The role of JNK in osteoblastic differentiation remains unclear.
Purpose of the Study:
- To investigate the role of JNK1 in BMP2-induced osteoblastic differentiation.
- To elucidate the molecular mechanism by which JNK1 affects osteoblastic differentiation.
- To identify potential therapeutic targets for enhancing bone formation.
Main Methods:
- Utilized C2C12 and MC3T3-E1 cell lines.
- Investigated JNK1 activation by BMP2.
- Employed JNK inhibitors, knockdown, and dominant-negative/constitutively active JNK1 constructs.
- Analyzed Runx2 phosphorylation at Ser104.
- Assessed osteoblastic differentiation markers (ALP expression, mineralization).
Main Results:
- BMP2 activates JNK1 in osteoblastic cells.
- JNK1 loss-of-function enhances BMP2-induced osteoblastic differentiation.
- JNK1 gain-of-function reduces BMP2-induced osteoblastic differentiation.
- JNK1 phosphorylates Runx2 at Ser104, inhibiting osteoblastic differentiation.
- Mutant Runx2 (Ser104Ala) mimics the effect of JNK inhibition.
Conclusions:
- JNK1 negatively regulates BMP2-induced osteoblastic differentiation via Runx2 phosphorylation at Ser104.
- Understanding this mechanism provides insights for developing strategies to promote osteoblastic differentiation and bone formation.
Related Concept Videos
TGF - β Signaling Pathway
MAPK Signaling Cascades
Osteoclasts in Bone Remodeling
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
